康芝药业 (300086.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(康芝药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
关 闭
完整财报对比
2021年一季报2020年年报2020年三季报2020年中报2020年一季报2019年年报2019年三季报2019年中报2019年一季报
主要指标:
 营业收入(元) 186,023,819.29921,642,902.81631,912,612.28411,318,235.60170,227,713.621,008,431,482.87762,855,686.87522,386,183.33265,904,523.80
 营业利润(元) -28,560,690.3258,021,879.0618,908,292.3913,829,905.65-13,476,627.90-19,092,049.8216,466,711.7015,750,272.1638,165,528.52
 利润总额(元) -29,046,409.2528,760,377.6310,871,620.9212,286,637.43-14,407,481.05-18,285,429.4218,451,326.7917,805,043.9138,026,106.64
 净利润(元) -30,020,660.1419,986,839.477,167,994.168,626,037.36-14,455,278.79-29,957,067.676,860,711.648,484,931.4330,376,417.69
 归属于母公司股东的净利润(元) -29,878,131.019,339,252.112,134,002.337,450,481.94-11,466,339.15-26,462,980.181,657,285.916,366,283.3827,121,214.97
盈利能力:
 销售毛利率(%) 38.4151.3049.5548.4644.5448.2747.1347.1447.27
 销售净利率(%) -16.142.171.132.10-8.49-2.970.901.6211.42
 净资产收益率(%) -2.020.620.140.50-0.75----
 总资产报酬率ROA(%) -1.041.820.980.87-0.52----
 投入资本回报率ROIC(%) -1.410.480.110.40-0.62-1.520.090.371.50
营运能力:
 存货周转率(次) 0.602.361.671.260.69----
 应收账款周转率(次) 1.787.485.253.141.45----
 总资产周转率(次) 0.080.380.270.180.07----
偿债能力:
 资产负债率(%) 38.5238.7236.1733.0133.5927.0023.5825.7723.53
 股东权益比率(%) 57.6057.4859.5362.6462.2168.2970.4469.0471.36
 已获利息倍数(倍) -7.812.931.902.65-4.74-0.372.533.1316.16
 流动比率 1.291.221.101.091.031.071.271.391.60
 速动比率 0.710.740.600.550.590.650.861.081.23
发展能力:
 营业收入增长率(%) 9.28-8.61-17.16-21.26-35.9814.2419.7134.1241.97
 营业利润增长率(%) -111.93403.9114.83-12.19-135.31-155.97-73.56-70.4515.99
 税后利润增长率(%) -160.57135.2928.7617.03-142.28-297.98-96.35-85.366.36
 净资产增长率(%) -0.970.27-2.871.54-5.36-2.96-2.17-21.41-16.02
 总资产增长率(%) 6.9519.1114.9411.928.560.64-2.51-7.87-1.69

前瞻产业研究院